CELPHARMA

Active

Public limited companyfounded 2025active for 1 yearLouizalaan 503, 1050 Elsene, Belgium25 active companies are registered at this addressKBO/BCE: BE 1025.475.981

Summary

The computed 12-month bankruptcy probability of CELPHARMA is 1.8% (moderate). The 2025 annual accounts show equity of €1.9m and a net result of €242,673. Its solvency ranks better than 55% of 6,139 sector peers (NACE 46, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

CELPHARMAActiveChecked score 56/100

Risk analysis Report Compare

Directors

5 directors, 1 in day-to-day management, no change since 2025

Board 5

CARLHIAN Antoine Marie Pierre

Director (not named in the articles) · since 22-07-2025

Current

GAVAZZI Gabriele

Director (not named in the articles) · since 22-07-2025

Current

RUESSMAN Laurent Antoine-Beaubien

Director (not named in the articles) · since 22-07-2025

Current

Think BVA

Présidence conseil d'administration · since 22-07-2025 · Private limited company · permanent representative: VAN ACKER Bernard Lucien Jean

Current

VAN ACKER Thomas Edward Lucien Jean

Director (not named in the articles) · since 22-07-2025

Current

Day-to-day management 1

Think BVA

Administrateur délégué à la gestion journalière · since 11-08-2025 · Private limited company · permanent representative: VAN ACKER Bernard Lucien Jean

Current

Permanent representatives 1

VAN ACKER Bernard Lucien Jean

Permanent representative · since 22-07-2025 · for Think BVA

Current

Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

5 people since 2025, 5 in office

All 5 In office 5

Board
Day-to-day management

Mandates per person, with start and end dates
Name	Functions and periods
CARLHIAN Antoine Marie Pierre	Director (not named in the articles), from 22-07-2025 to date
GAVAZZI Gabriele	Director (not named in the articles), from 22-07-2025 to date
RUESSMAN Laurent Antoine-Beaubien	Director (not named in the articles), from 22-07-2025 to date
Think BVA	Director (not named in the articles), from 22-07-2025 to date Administrateur délégué à la gestion journalière, from 11-08-2025 to date
VAN ACKER Thomas Edward Lucien Jean	Director (not named in the articles), from 22-07-2025 to date

See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds

At incorporation act of 22-07-2025 ↗

Bernard VAN ACKER 480,000 shares (44.6%)
Gabriele GAVAZZI 155,955 shares (14.5%)
Marc BRAY 214,045 shares (19.9%)
Florence RUESSMANN 30,000 shares (2.8%)
Yves BEUDIN 25,000 shares (2.3%)
SBAYE CONSULTING 10,000 shares (0.9%)
Laurent RUESSMANN 52,968 shares (4.9%)
LEYS IMMO INVEST 108,000 shares (10%)
VAN ACKER Bernard Lucien Jean 480,000 shares

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

11-08-2025 Capital increase of €878,981.56 · to €1,003,110.35 · 1,043,986 new shares
22-07-2025 Incorporation · €905,908.63 · 1,075,968 shares